Charles Schwab’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-833
| Closed | -$13.7K | – | 3508 |
|
|
2024
Q3 | $13.7K | Hold |
833
| – | – | ﹤0.01% | 3498 |
|
|
2024
Q2 | $15.9K | Hold |
833
| – | – | ﹤0.01% | 3599 |
|
|
2024
Q1 | $22.3K | Hold |
833
| – | – | ﹤0.01% | 3428 |
|
|
2023
Q4 | $11.4K | Hold |
833
| – | – | ﹤0.01% | 3517 |
|
|
2023
Q3 | $12.9K | Hold |
833
| – | – | ﹤0.01% | 3546 |
|
|
2023
Q2 | $18K | Hold |
833
| – | – | ﹤0.01% | 3571 |
|
|
2023
Q1 | $14.8K | Hold |
833
| – | – | ﹤0.01% | 3528 |
|
|
2022
Q4 | $14.1K | Hold |
833
| – | – | ﹤0.01% | 3521 |
|
|
2022
Q3 | $28K | Hold |
833
| – | – | ﹤0.01% | 3446 |
|
|
2022
Q2 | $47K | Hold |
833
| – | – | ﹤0.01% | 3399 |
|
|
2022
Q1 | $49K | Hold |
833
| – | – | ﹤0.01% | 3526 |
|
|
2021
Q4 | $60K | Buy |
+833
| New | +$60K | ﹤0.01% | 3495 |
|
|
2021
Q3 | – | Sell |
-5,073
| Closed | -$489K | – | 3534 |
|
|
2021
Q2 | $489K | Sell |
5,073
-3,101
| -38% | -$299K | ﹤0.01% | 3172 |
|
|
2021
Q1 | $982K | Buy |
8,174
+183
| +2% | +$22K | ﹤0.01% | 2866 |
|
|
2020
Q4 | $1.05M | Buy |
7,991
+604
| +8% | +$79.1K | ﹤0.01% | 2756 |
|
|
2020
Q3 | $781K | Buy |
7,387
+918
| +14% | +$97.1K | ﹤0.01% | 2731 |
|
|
2020
Q2 | $1.67M | Buy |
6,469
+695
| +12% | +$179K | ﹤0.01% | 2473 |
|
|
2020
Q1 | $2.57M | Buy |
5,774
+132
| +2% | +$58.7K | ﹤0.01% | 2168 |
|
|
2019
Q4 | $3.81M | Buy |
5,642
+3,322
| +143% | +$2.25M | ﹤0.01% | 2165 |
|
|
2019
Q3 | $859K | Buy |
2,320
+174
| +8% | +$64.4K | ﹤0.01% | 2613 |
|
|
2019
Q2 | $386K | Buy |
+2,146
| New | +$386K | ﹤0.01% | 2931 |
|